Drugs / trolamine salicylate
trolamine salicylate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04846348 | Jul → Sep 2021 | cutaneous mastocytosis | Joseph Butterfield | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trolamine salicylate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04846348 ↗ |
| Known as | Neo heliopan ts | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107288 ↗ |
| Known as | Neotan w | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107288 ↗ |
| Known as | Tea-salicylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107288 ↗ |
| Known as | Triethanolamine salicylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107288 ↗ |
| Action | Inhibit | “Trolamine salicylate Prostaglandin inhibitor, antiinflammatory” NCT04846348 ↗ |
| Modality | Small molecule | — CHEMBL2107288 ↗ |